Skip to main content
Top

11-01-2012 | Gestational diabetes | Review | Article

Gestational diabetes mellitus: risks and management during and after pregnancy

Authors: Thomas A. Buchanan, Anny H. Xiang, Kathleen A. Page

Abstract

Gestational diabetes mellitus (GDM) carries a small but potentially important risk of adverse perinatal outcomes and a long-term risk of obesity and glucose intolerance in offspring. Mothers with GDM have an excess of hypertensive disorders during pregnancy and a high risk of developing diabetes mellitus thereafter. Diagnosing and treating GDM can reduce perinatal complications, but only a small fraction of pregnancies benefit. Nutritional management is the cornerstone of treatment; insulin, glyburide and metformin can be used to intensify treatment. Fetal measurements complement maternal glucose monitoring in the identification of pregnancies that require such intensification. Glucose testing shortly after delivery can stratify the short-term diabetes risk in mothers. Thereafter, annual glucose and HbA1c testing can detect deteriorating glycaemic control, a harbinger of future diabetes mellitus, usually type 2 diabetes mellitus. Interventions that mitigate obesity or its metabolic effects are most potent in preventing or delaying diabetes mellitus. Lifestyle modification is the primary approach; use of medications for diabetes prevention after GDM remains controversial. Family planning enables optimization of health in subsequent pregnancies. Breastfeeding may reduce obesity in children and is recommended. Families should be encouraged to help children adopt lifestyles that reduce the risk of obesity.

Nat Rev Endocrinol 2012;8:639–649. doi:10.1038/nrendo.2012.96

Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. The disease has important health implications for mother and child. This Review discusses current evidence for the importance of GDM, opportunities to reduce risk to mother and child and recommendations for clinical care.

Literature
  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 35 (Suppl. 1), S64–S71 (2012).
  2. Buchanan, T. A., Xiang, A., Kjos, S. L. & Watanabe, R. M. What is gestational diabetes? Diabetes Care 30 (Suppl. 2), S105–S111 (2007).
  3. Metzger, B. E. et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358, 1991–2002 (2008).
  4. Metzger, B. E. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676–682 (2010).
  5. Sacks, D. A. et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35, 526–528 (2012).
  6. Ryan, E. A. Diagnosing gestational diabetes. Diabetologia 54, 480–486 (2011).
  7. Long, H. Diagnosing gestational diabetes: can expert opinions replace scientific evidence. Diabetologia 54, 2211–2213 (2011).
  8. Paglia, M. J. & Coustan, D. R. Gestational diabetes: evolving diagnostic criteria. Curr. Opin. Obstet. Gynecol. 23, 72–75 (2011).
  9. Schafer, U. M. et al. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am. J. Obstet. Gynecol. 177, 1165–1171 (1997).
  10. Dabelea, D. et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28, 579–584 (2005).
  11. Ferrara, A., Kahn, H. S., Quesenberry, C. P., Riley, C. & Hedderson, M. M. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet. Gynecol. 103, 526–533 (2004).
  12. Xiang, A. H. et al. Racial and ethnic disparities in diabetes risk after gestational diabetes. Diabetologia 54, 3016–3021 (2011).
  13. Xiang, A. H. et al. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 48, 848–854 (1999).
  14. Petersen, J. S. et al. GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy. Diabetologia 39, 1329–1333 (1996).
  15. Catalano, P. M., Tyzbir, E. D. & Sims, E. A. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 13, 478–482 (1990).
  16. Mauricio, D. et al. Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes shortly after pregnancy. Diabetes Nutr. Metab. 5, 237–241 (1992).
  17. Kousta, E. et al. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet. Med. 18, 683–684 (2001).
  18. Weng, J. et al. Screening for MODY mutations, GAD antibodies, and type 1 diabetes–associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care 25, 68–71 (2002).
  19. Chen, Y., Liao, W. X., Roy, A. C., Loganath, A. & Ng, S. C. Mitochondrial gene mutations in gestational diabetes mellitus. Diabetes Res. Clin. Pract. 48, 29–35 (2000).
  20. Catalano, P. M. et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am. J. Physiol. 264, E60–E67 (1993).
  21. Catalano, P. M., Huston, L., Amini, S. B. & Kalhan, S. C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am. J. Obstet. Gynecol. 180, 903–916 (1999).
  22. Homko, C., Sivan, E., Chen, X., Reece, E. A. & Boden, G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 86, 568–573 (2001).
  23. Naylor, C. D., Sermer, M., Chen, E. & Sykora, K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? JAMA 275, 1165–1170 (1996).
  24. O'Sullivan, J. B. Diabetes after GDM. Diabetes 40 (Suppl. 2), 131–135 (1991).
  25. Xiang, A. H., Kjos, S. L., Takayanagi, M., Trigo, E. & Buchanan, T. A. Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes 59, 2625–2630 (2010).
  26. Xiang, A. H., Kawakubo, M., Trigo, E., Kjos, S. L. & Buchanan, T. A. Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care 33, 396–401 (2010).
  27. Retnakaran, R. et al. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J. Clin. Endocrinol. Metab. 95, 670–677 (2010).
  28. Sullivan, S. D., Umans, J. G. & Ratner, R. Gestational diabetes; implications for cardiovascular health. Curr. Diab. Rep. 12, 43–52 (2012).
  29. Retnakaran, R. & Shah, B. R. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 181, 371–376 (2009).
  30. Silverman, B. L. et al. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes 40 (Suppl. 2), S121–S125 (1991).
  31. Hillier, T. A. et al. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 30, 2287–2292 (2007).
  32. Dabelea, D. et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case–Control Study. Diabetes Care 31, 1422–1426 (2008).
  33. Krishnaveni, G. V. et al. Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children. Diabetes Care 33, 402–404 (2010).
  34. Whitaker, R. C., Pepe, M. S., Seidel, K. D., Wright, J. A. & Knopp, R. H. Gestational diabetes and the risk of offspring obesity. Pediatrics 101, E9 (1998).
  35. Catalano, P. M. et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am. J. Clin. Nutr. 90, 1303–1313 (2009).
  36. Dabelea, D. et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49, 2208–2211 (2000).
  37. Silverman, B. L., Rizzo, T. A., Cho, N. H. & Metzger, B. E. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care 21 (Suppl. 2), B142–B149 (1998).
  38. Crume, T. L. et al. The impact of in utero exposure to diabetes on childhood body mass index growth trajectories: the EPOCH study. J. Pediatr. 158, 941–946 (2011).
  39. Nathan, D. M. et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32, 193–203 (2009).
  40. [No authors listed] Screening for gestational diabetes mellitus: U. S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 148, 759–765 (2008).
  41. Scott, D. A., Loveman, E., McIntyre, I. & Waugh, N. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol. Assess. 6, 1–161 (2002).
  42. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care, 15–23 (Health Canada, Ottawa, 1994).
  43. Crowther, C. A. et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352, 2477–2486 (2005).
  44. Landon, M. B. et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med. 361, 1339–1348 (2009).
  45. Horvath, K. et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 340, c1395 (2010).
  46. Ohno, M. S., Sparks, T. N., Cheng, Y. W. & Caughey, A. B. Treating mild gestational diabetes: a cost-effectiveness analysis. Am. J. Obstet. Gynecol. 205, 282.e1–282.e7 (2011).
  47. Tuomilehto, J. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343–1350 (2001).
  48. Buchanan, T. A. et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51, 2796–2803 (2002).
  49. Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393–403 (2002).
  50. Chaisson, J. L. et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359, 2072–2077 (2002).
  51. Gerstein, H. C. et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: randomised controlled trial. Lancet 368, 1096–1105 (2006).
  52. DeFronzo, R. A. et al. Pioglitazone for diabetes prevention in impaired glucose tolerance. N. Engl. J. Med. 364, 1104–1115 (2011).
  53. Buchanan, T. A. (How) can we prevent type 2 diabetes? Diabetes 56, 1502–1507 (2007).
  54. Xiang, A. H. et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55, 517–522 (2006).
  55. Ratner, R. E. et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle intervention. J. Clin. Endocrinol. Metab. 93, 4774–4779 (2008).
  56. Pettitt, D. J. & Knowler, W. C. Long-term effects of the intrauterine environment, birth weight, and breast-feeding on Pima Indians. Diabetes Care 21 (Suppl. 2), B138–B141 (1998).
  57. Mayer-Davis, E. J. et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCh for diabetes in youth case–control study. Diabetes Care 31, 470–475 (2008).
  58. Gillman, M. W. et al. Effect of treatment of gestational diabetes on obesity in the next generation. Diabetes Care 33, 964–968 (2010).
  59. Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R. & Moore, P. M. Metformin versus insulin for treatment of gestational diabetes. N. Engl. J. Med. 358, 2003–2015 (2008).
  60. Rowan, J. A. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 34, 2279–2284 (2011).
  61. Knopp, R. H., Magee, M. S., Raisys, V. & Benedetti, T. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes 40 (Suppl. 2), 165–171 (1991).
  62. Peterson, C. M. & Jovanovic-Peterson, L. Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes 40 (Suppl. 2), 172–174 (1991).
  63. Clapp, J. F. 3rd. Effect of dietary carbohydrate on the glucose and insulin response to mixed caloric intake and exercise in both nonpregnant and pregnant women. Diabetes Care 21 (Suppl. 2), B107–B112 (1998).
  64. Major, C. A., Henry, M. J., De Veciana, M. & Morgat, M. A. The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet. Gynecol. 91, 600–604 (1998).
  65. de Veciana, M. et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N. Engl. J. Med. 333, 1237–1241 (1995).
  66. Naylor, C. D., Sermer, M., Chen, E. & Sykora, K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? JAMA 275, 1165–1170 (1996).
  67. [No authors listed] Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58, 453–459 (2009).
  68. Kjos, S. L. et al. A randomized controlled trial utilizing glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 24, 1904–1910 (2001).
  69. Buchanan, T. A. et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 17, 275–283 (1994).
  70. Langer, O. et al. Glycemic control in gestational diabetes mellitus—how tight is tight enough: small for gestational age versus large for gestational age? Am. J. Obstet. Gynecol. 161, 646–653 (1989).
  71. Bung, P., Artal, R., Khodiguian, N. & Kjos, S. Exercise in gestational diabetes. An optional therapeutic approach? Diabetes 40 (Suppl. 2), 182–185 (1991).
  72. Jovanovic-Peterson, L. & Peterson, C. M. Is exercise safe or useful for gestational diabetic women? Diabetes 40 (Suppl. 2), 179–181 (1991).
  73. Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M. & Gonzales, O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med. 343, 1134–1138 (2000).
  74. Kjos, S. L. et al. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 44, 586–591 (1995).
  75. Kim, C., Newton, K. M. & Knopp, R. H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25, 1862–1868 (2002).
  76. Hattersley, A. T. & Pearson, E. R. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology 147, 2657–2663 (2006).
  77. Nathan, D. M. et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30, 753–759 (2007).
  78. Peters, R. K., Kjos, S. L., Xiang, A. & Buchanan T. A. Long-term diabetogenic effect of a single pregnancy in women with previous gestational diabetes mellitus. Lancet 347, 227–230 (1996).
  79. Ehrlich, S. F. et al. Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy. Obstet. Gynecol. 117, 1323–1330 (2011).
  80. Kjos, S. L. et al. Oral contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes. JAMA 280, 533–538 (1998).
  81. Xiang, A. H., Kawakubo, M., Kjos, S. L. & Buchanan, T. A. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 29, 613–617 (2006).

©Nature Publishing Group 2012

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »